Viewing Study NCT05681260


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-30 @ 9:52 AM
Study NCT ID: NCT05681260
Status: RECRUITING
Last Update Posted: 2025-02-13
First Post: 2022-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
Sponsor: Children's Cancer Group, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module